Called IQcast, the feature tells users whether they have a low, medium or high chance of dropping below the target blood glucose range within the next one to four hours. These individual-specific predictions are generated by analyzing data collected through Sugar.IQ app and the Guardian Connect device. The Sugar.IQ app is currently available in the App Store for free download. The FDA-cleared app uses IBM Watson Health's AI and analytics tools to help users see how their glucose levels change during the day, and includes a smart food logging system, motivational insights, a glycemic assistant, a data tracker and a glycemic insights feature. Hypoglycemia -- defined by the American Diabetes Association as a blood glucose level lower than 70 mg/dL -- can lead to symptoms ranging from lightheadedness and lethargy to vision impairment and seizures.
Amazon has Alexa, Apple has Siri, Microsoft has Cortana, Google has Google Assistant. As a member of the general public, you could ask any of those AI interfaces a question, depending on what device you owned -- iPhone, Echo, PC, or Android -- and most of the time get a coherent answer. These digital assistants have become the emerging user interface. IBM Watson is also an AI platform that can answer questions, but it has always been in a different category. Sure, it's been known to the general public, probably first through its triumph over Jeopardy champ Ken Jennings.
The American Diabetes Association and IBM Watson Health will partner on a long-term collaboration to bring together the cognitive computing power of Watson and the ADA's vast clinical and research data. Kevin L. Hagen, ADA CEO, said the ADA and IBM Watson Health will work to build a first-of-its-kind diabetes advisor for patients and caregivers, as well as develop Watson-powered solutions to optimize clinical, research and lifestyle decisions. "The goal of this endeavor is to develop and introduce cognitive technologies that support clinicians, researchers and people living with diabetes so that we can accelerate discoveries, personalize treatment and care, and improve the lives of all people affected by diabetes," Hagen said while announcing the partnership. "We also see potential to address social determinants of health." Unlike traditional computing systems that are programmed, systems like IBM Watson learn at scale, explained IBM General Manager David Kenny.
IBM said it is launching a Watson certification for developers. The move comes as IBM is increasingly courting developers and broadening the ecosystem for Watson and cognitive computing. The test was created by a panel of 20 cognitive computing experts in various industries where Watson plays -- healthcare, banking, commerce, etc., according to a blog post. Should a developer pass the exam they'll be noted an IBM Certified Application Developer and get a digital badge. The exam is delivered via Pearson VUE and can be taken at its test centers.